Those questions led us to approach this Nature issue with humility. We try to grapple with them all the time—MIT Technology ...
Using CRISPR, multiomics, and machine learning, molecular biologist Larschan unravels the mysteries of the X chromosome.
Qatar Tribune on MSN
Sidra Medicine introduces gene-editing therapy for sickle cell disease and thalassaemia
Tribune News NetworkDohaSidra Medicine, a member of Qatar Foundation, has been qualified by Vertex Pharmaceuticals as one of a limited number of hospitals in the world to administer Casgevy, a ...
CRISPR Therapeutics plans to post clinical trial updates for multiple candidates this year. The company's stock could jump if ...
Investigating a common gene in three very different species – axolotls, mice and zebrafish – scientists have discovered the ...
The Chosun Ilbo on MSN
Breakthrough Prize honors gene therapy pioneers
In December 2023, the U.S. Food and Drug Administration (FDA) approved ‘Casgevy,’ a treatment utilizing CRISPR gene-editing ...
The Pairwise Fulcrum® platform includes proprietary gene editing tools, enzymes, and trait libraries that enable precise genetic changes, unlocking plants’ inherent potential and significantly ...
To accelerate discovery, scientists from ATCC and the Broad Institute collaborated to engineer a panel of drug-resistant NSCLC models using CRISPR gene editing and gene overexpression techniques.
SlMYB32 was identified as a repressor regulating phenylpropanoid pathway. CRISPR/Cas9-mediated mutagenesis of SlMYB32 results ...
Crispr Therapeutics is an emerging gene editing company focused on the development of Crispr/Cas9-based therapeutics. The company's proprietary platform specializes in clustered regularly interspaced ...
National Institutes of Health (NIH) released the following: A National Institutes of Health (NIH)-funded research team has ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results